StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.96−0.06 (-2.97%)

Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –

Compugen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was $31.63M, down 36.2% from the year before. The highest annual figure on record is $49.60M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$31.63M-36.2%
FY2024Dec 31, 2024$49.60M–
FY2023Dec 31, 2023-$35.89M–
FY2022Dec 31, 2022-$34.11M–
FY2021Dec 31, 2021-$22.69M–
FY2020Dec 31, 2020-$28.32M–
FY2019Dec 31, 2019-$27.89M–
FY2018Dec 31, 2018-$13.29M–
FY2017Dec 31, 2017-$30.66M–
FY2016Dec 31, 2016-$19.82M–
FY2015Dec 31, 2015-$25.61M–
FY2014Dec 31, 2014-$11.15M–
FY2013Dec 31, 2013-$6.44M–
FY2012Dec 31, 2012-$10.85M–
FY2011Dec 31, 2011-$9.25M–
FY2010Dec 31, 2010-$4.28M–
FY2009Dec 31, 2009-$7.45M–

More Compugen figures

See a number that looks wrong?